Carrera Capital Advisors increased its position in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 31.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,308 shares of the health services provider's stock after acquiring an additional 3,435 shares during the quarter. Carrera Capital Advisors' holdings in Universal Health Services were worth $2,567,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the company. Cypress Capital Group raised its stake in shares of Universal Health Services by 54.5% during the 4th quarter. Cypress Capital Group now owns 1,491 shares of the health services provider's stock worth $268,000 after acquiring an additional 526 shares in the last quarter. Victory Capital Management Inc. increased its stake in Universal Health Services by 12.7% during the 4th quarter. Victory Capital Management Inc. now owns 46,890 shares of the health services provider's stock valued at $8,413,000 after purchasing an additional 5,267 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in Universal Health Services by 30.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 455 shares of the health services provider's stock valued at $81,000 after purchasing an additional 107 shares in the last quarter. Metis Global Partners LLC increased its stake in Universal Health Services by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 1,988 shares of the health services provider's stock valued at $357,000 after purchasing an additional 90 shares in the last quarter. Finally, US Bancorp DE increased its stake in shares of Universal Health Services by 8.8% in the fourth quarter. US Bancorp DE now owns 2,435 shares of the health services provider's stock worth $437,000 after acquiring an additional 197 shares during the period. Institutional investors own 86.05% of the company's stock.
Analysts Set New Price Targets
UHS has been the topic of a number of recent analyst reports. Barclays lowered their price target on shares of Universal Health Services from $271.00 to $249.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. The Goldman Sachs Group cut shares of Universal Health Services from a "buy" rating to a "neutral" rating and reduced their target price for the company from $228.00 to $198.00 in a research report on Monday, December 16th. TD Cowen reduced their target price on shares of Universal Health Services from $275.00 to $251.00 and set a "buy" rating for the company in a research report on Tuesday, November 26th. Wells Fargo & Company reduced their target price on shares of Universal Health Services from $285.00 to $230.00 and set an "overweight" rating for the company in a research report on Monday, November 25th. Finally, StockNews.com cut shares of Universal Health Services from a "strong-buy" rating to a "buy" rating in a research report on Saturday, November 9th. Six equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $231.17.
Check Out Our Latest Stock Report on Universal Health Services
Universal Health Services Stock Performance
UHS traded down $3.38 during trading on Friday, hitting $172.04. The stock had a trading volume of 1,876,366 shares, compared to its average volume of 711,076. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.28 and a current ratio of 1.39. The firm has a market capitalization of $11.35 billion, a P/E ratio of 11.44, a PEG ratio of 0.53 and a beta of 1.32. The company's 50-day moving average price is $184.02 and its 200 day moving average price is $203.70. Universal Health Services, Inc. has a twelve month low of $152.68 and a twelve month high of $243.25.
Universal Health Services (NYSE:UHS - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported $4.92 EPS for the quarter, topping the consensus estimate of $4.21 by $0.71. The company had revenue of $4.11 billion for the quarter, compared to analyst estimates of $4.01 billion. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. On average, equities research analysts forecast that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.
Universal Health Services Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a $0.20 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.80 annualized dividend and a dividend yield of 0.47%. Universal Health Services's dividend payout ratio is presently 4.75%.
Insider Buying and Selling
In related news, Director Maria Ruderman Singer sold 1,614 shares of the business's stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $191.15, for a total value of $308,516.10. Following the sale, the director now directly owns 5,879 shares in the company, valued at $1,123,770.85. The trade was a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 16.10% of the company's stock.
About Universal Health Services
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Read More
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
